% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • larshansson18 larshansson18 Sep 28, 2009 3:21 PM Flag

    Mail answer

    This is from a post att

    "Svar idag fran Epicept:
    Mon, 28 Sep 2009 11:27:25
    1. Ang. (Concerning)

    "The article is discussing the use of higher dose daunorubicin, an chemotherapy drug used to induce first remission in AML patients. You are correct that this treatment is at least one step ahead of Ceplene, namely induction and potentially consolidation treatment. Ceplene would be used in these patients who successfully achieve complete remission".

    2. Ang. varfor det ar sa otroligt tyst fran Bolaget (Concerning why it is so silent from the CO):

    "We report news when we have news to report. The resolution of the issues you reference cannot be achieved by EpiCept alone because we are working with third parties who have significant control over the timing. We expect that news will be forthcoming soon and we will report it ASAP after receipt of the information".

    Bob Cook
    EpiCept Corporation

    Spannande att (thrilling that..)"news will be forthcoming SOON"!"

    For what it is worth.

0.415+0.015(+3.75%)Jul 1 3:59 PMEDT